Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 100   

Articles published

CBST 70.93 -1.49 (-2.06%)
price chart
New Cubist Pharmaceuticals chief executive will be Robert J. Perez
Cubist Pharmaceuticals Inc. said Monday it plans to install a new chief executive, a surprise move that raised questions about whether the Lexington company will keep expanding as the leading US maker of antibiotics or become a takeover target.
Cubist Pharma CEO Bonney will step down Dec. 31  San Francisco Chronicle (subscription)
Related articles »  
Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line ...
Last year, Cubist acquired Dificid when it bought Optimer Pharmaceuticals for $551 million, and Dificid's sales total $47.7 million through the first nine months of 2014.
Cubist Pharmaceuticals Shares Up 3.3% on Strong Earnings (CBST)  sleekmoney
Cubist Pharmaceuticals (CBST) - Market Digest  AVAFIN
Related articles »  
Cubist Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for CBST
In trading on Wednesday, shares of Cubist Pharmaceuticals Inc. (Symbol: CBST) crossed above their 200 day moving average of $69.01, changing hands as high as $69.84 per share.
Cubist Pharmaceuticals Inc.: Cubist Reports Third Quarter 2014 Financial Results
LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2014.
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum ...
Investor-Edge has initiated coverage on the following equities: Intrexon Corporation (NYSE: XON), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Sangamo BioSciences Inc. (NASDAQ: SGMO), and Cubist ...
Related articles »  
Trader's Watch List: Cubist Pharmaceuticals Inc (CBST), Panera Bread Co ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) released results for the third quarter ended September 30, 2014. The Company will host a conference call and webcast today at 5:00 p.m.
Stocks Alert: Energy XXI (Bermuda) Limited (NASDAQ:EXXI), Ohr ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) said its president and chief operating officer Robert J. Perez will take over as Chief Executive Officer, effective January 1, 2015, replacing Michael Bonney who is retiring.
Cubist Pharmaceuticals (CBST) Announces Quarterly Earnings, Beats Estimates ...
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) released its earnings data on Tuesday. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.54, Stock Ratings ...
Cubist Pharmaceuticals (CBST) Releases Quarterly Earnings Results, Beats ...
Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ:CBST) released its earnings data on Tuesday. The company reported $0.58 earnings per share for the quarter, beating the analysts' consensus estimate of $0.04 by $0.54, ...
Related articles »  
Trend Analysis Report � Tesoro Logistics LP (NYSE:TLLP), Cubist ...
Cubist Pharmaceuticals Inc (CBST) reported that results for the third quarter ended September 30, 2014. The Company will host a conference call and webcast today at 5:00 p.m.
Related articles »